• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION HANCOCK; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION HANCOCK; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number HC150-12
Device Problems Gradient Increase (1270); Obstruction of Flow (2423)
Patient Problems Pulmonary Regurgitation (2023); Pulmonary Valve Stenosis (2024)
Event Date 07/12/2012
Event Type  Injury  
Manufacturer Narrative
Citation: lurz p et al.Impact of reduction in right ventricular pressure and/or volume overload by percutaneous pulmonary valve implantation on biventricular response to exercise: an exercise stress real-time cmr study.Eur heart j.2012 oct;33(19):2434-41.Doi: 10.1093/eurheartj/ehs200.Epub 2012 jul 12.Earliest date of publish used for event date in.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without the return of the product, no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding the use of real-time cardiac magnetic resonance imaging to evaluate potential differences in biventricular response to exercise in patients with pulmonary stenosis and pulmonary regurgitation pre- and post- percutaneous pulmonary valve implantation.The study population included 17 patients (predominantly male; mean age 19 years; mean weight 62 kg), 2 of which were previously implanted with medtronic hancock valved conduits (no serial numbers provided).Among all patients, adverse events included: pulmonary stenosis (with high right ventricular outflow tract mean gradients) or pulmonary regurgitation requiring percutaneous pulmonary valve implantation.Based on the available information, medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8680772
MDR Text Key147440526
Report Number2025587-2019-01865
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P790007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 06/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/07/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberHC150-12
Device Catalogue NumberHC150-12
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/20/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age19 YR
Patient Weight62
-
-